Blood markers of oxidative stress in Alzheimer's disease.

Journal of Cellular and Molecular Medicine
Alice Skoumalová, Jakub Hort

Abstract

Alzheimer's disease (AD) represents a highly common form of dementia, but can be diagnosed in the earlier stages before dementia onset. Early diagnosis is crucial for successful therapeutic intervention. The introduction of new diagnostic biomarkers for AD is aimed at detecting underlying brain pathology. These biomarkers reflect structural or biochemical changes related to AD. Examination of cerebrospinal fluid has many drawbacks; therefore, the search for sensitive and specific blood markers is ongoing. Investigation is mainly focused on upstream processes, among which oxidative stress in the brain is of particular interest. Products of oxidative stress may diffuse into the blood and evaluating them can contribute to diagnosis of AD. However, results of blood oxidative stress markers are not consistent among various studies, as documented in this review. To find a specific biochemical marker for AD, we should concentrate on specific metabolic products formed in the brain. Specific fluorescent intermediates of brain lipid peroxidation may represent such candidates as the composition of brain phospholipids is unique. They are small lipophilic molecules and can diffuse into the blood stream, where they can then be detected. We p...Continue Reading

References

Nov 1, 1994·Annals of Neurology·P MecocciM F Beal
Sep 1, 1995·Movement Disorders : Official Journal of the Movement Disorder Society·J E AhlskogE Kokmen
Aug 1, 1997·Acta Neurologica Scandinavica·G P ParaskevasC Papageorgiou
Jan 1, 1997·Journal of Neural Transmission·F J Jiménez-JiménezR Enríquez-de-Salamanca
Mar 17, 1998·Biochemical and Biophysical Research Communications·P OdettiM Tabaton
Jun 5, 1998·The Journal of Biological Chemistry·L J RobertsJ D Morrow
Sep 28, 1998·Annals of Neurology·T J MontineL J Roberts
Oct 22, 1998·Neurology·P MecocciU Senin
Dec 16, 1998·International Journal of Geriatric Psychiatry·S RivièreB Vellas
Jan 13, 1999·International Journal of Geriatric Psychiatry·A J SinclairS R Maxwell
Apr 21, 1999·QJM : Monthly Journal of the Association of Physicians·C J FoyJ T Lawson
Jul 20, 1999·European Journal of Clinical Investigation·M G RepettoS F Llesuy
Jun 30, 2000·Biochemical and Biophysical Research Communications·S ShimohamaS Fujimoto
Aug 15, 2000·Journal of Structural Biology·S VaradarajanD A Butterfield
Aug 26, 2000·Experimental Gerontology·T LynchA I Bush
Aug 31, 2000·Biochemical and Biophysical Research Communications·C C ConradR W Gracy
Nov 23, 2000·Journal of Neuropathology and Experimental Neurology·A NunomuraM A Smith
Aug 7, 2001·Journal of Neuropathology and Experimental Neurology·A NunomuraM A Smith
Aug 22, 2001·Lancet·A CagninR B Banati
Aug 31, 2001·QJM : Monthly Journal of the Association of Physicians·L T McGrathA P Passmore
Jan 5, 2002·Neurobiology of Aging·Mónika MóroczIstván Raskó
May 16, 2002·Neurobiology of Aging·C E TeunissenC De Bruijn
May 22, 2002·Archives of Neurology·Patrizia MecocciM Flint Beal
Jun 11, 2002·Biochemical and Biophysical Research Communications·Joungil ChoiRobert W Gracy
Jun 12, 2002·Archives of Neurology·Domenico PraticòJohn Q Trojanowski
Sep 5, 2002·Annals of Neurology·Thomas J MontineJason D Morrow
Nov 7, 2002·Free Radical Biology & Medicine·Cristina CecchiGianfranco Liguri
Jun 20, 2003·Experimental Gerontology·A SkoumalovaJ Wilhelm
Nov 5, 2003·Proteomics·Han-Ling YuHyman M Schipper
Sep 17, 2004·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Ela KadiogluAli Esat Karakaya
Jan 18, 2005·Neurobiology of Aging·E GrünblattP Riederer

❮ Previous
Next ❯

Citations

Mar 26, 2014·Neuroscience Bulletin·Zhichun Chen, Chunjiu Zhong
Mar 28, 2013·Oxidative Medicine and Cellular Longevity·Ana-Maria EnciuBogdan O Popescu
Nov 30, 2013·International Journal of Alzheimer's Disease·Nathalie ArnalCarlos A Marra
Jul 8, 2014·Oxidative Medicine and Cellular Longevity·Antonio AyalaSandro Argüelles
Oct 30, 2016·Antioxidants·Nur Adalier, Heath Parker
Mar 23, 2017·Journal of the Neurological Sciences·Pramila Bakthavachalam, Prakash Srinivasan Timiri Shanmugam
Jan 31, 2017·Journal of the Neurological Sciences·Ana García-BlancoConsuelo Cháfer-Pericás
Feb 20, 2014·Metallomics : Integrated Biometal Science·Douglas B Kell, Etheresia Pretorius
Apr 10, 2014·Integrative Biology : Quantitative Biosciences From Nano to Macro·Etheresia Pretorius, Douglas B Kell
Jul 19, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Pei-Pei Guan, Pu Wang
May 18, 2019·International Journal of Molecular Sciences·Jakub HortFrancesco Angelucci
Mar 5, 2015·Journal of Alzheimer's Disease : JAD·Joanna WojsiatUrszula Wojda
Dec 17, 2015·Geriatrics & Gerontology International·Hirokuni HatanakaToshihiko Iwamoto
Jan 17, 2020·Current Pharmaceutical Design·Patricia Regina ManzineMarcia Regina Cominetti
Mar 19, 2016·Journal of Cellular and Molecular Medicine·Zuzana ChmátalováAlice Skoumalová
Sep 12, 2017·Frontiers in Aging Neuroscience·Cristiana Carelli-Alinovi, Francesco Misiti
Jul 22, 2018·Frontiers in Neuroscience·Alexandra Moreno-GarcíaMiguel Calero
Jul 30, 2019·Journal of Alzheimer's Disease : JAD·Irene Martínez de TodaMónica De la Fuente
Nov 5, 2015·Geriatrics & Gerontology International·Hirokuni HatanakaHirofumi Sakurai
Aug 5, 2017·Frontiers in Neurology·Palaniswamy RaniChellappa Rani Cathrine
Dec 18, 2020·Frontiers in Cell and Developmental Biology·Yao Tong, Shusheng Wang
May 4, 2021·Journal of Alzheimer's Disease : JAD·Fahad Somaa
Aug 24, 2021·Journal of Alzheimer's Disease : JAD·Federica CioffiKerensa Broersen

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
MDA

Related Concepts

Related Feeds

Alzheimer's Disease: Early Markers

Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive and behavioral decline. Targeting markers in the earliest stages of the disease may mitigate the progression of AD. This feed focuses on early diagnosis and markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.